Efficacy and safety of Exubera (inhaled insulin) therapy in subjects with type 2 diabetes mellitus not well controlled with combination oral agents: a three-month, outpatient, parallel comparative trial.

Trial Profile

Efficacy and safety of Exubera (inhaled insulin) therapy in subjects with type 2 diabetes mellitus not well controlled with combination oral agents: a three-month, outpatient, parallel comparative trial.

Completed
Phase of Trial: Phase III

Latest Information Update: 24 Mar 2009

At a glance

  • Drugs Antihyperglycaemics; Insulin
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Sponsors Pfizer
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 04 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top